NasdaqGS:ARQTBiotechs
A Look At Arcutis Biotherapeutics (ARQT) Valuation After Recent Share Price Weakness
Why Arcutis Biotherapeutics Stock Is On Investors’ Radar
Arcutis Biotherapeutics (ARQT) shares have drawn attention after a mixed stretch, with negative returns over the past week, month, and past 3 months, alongside a positive 1 year total return and a value score of 6.
See our latest analysis for Arcutis Biotherapeutics.
The recent 7 day share price return of a 7.14% decline and 30 day share price return of a 14% decline contrast with a 1 year total shareholder return of 33.98%. This...